Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 21088 | 434 | 31.0 | 53% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
| 41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
| 3405 | 2 | LOTEPREDNOL ETABONATE//PRODRUG//ANTEDRUG | 1608 |
| 21088 | 1 | LOTEPREDNOL ETABONATE//CHEMICAL DELIVERY SYSTEM//NBP ASSAY | 434 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | LOTEPREDNOL ETABONATE | authKW | 1064137 | 5% | 69% | 22 |
| 2 | CHEMICAL DELIVERY SYSTEM | authKW | 651288 | 4% | 51% | 18 |
| 3 | NBP ASSAY | authKW | 351785 | 1% | 100% | 5 |
| 4 | SOFT DRUGS | authKW | 271367 | 2% | 43% | 9 |
| 5 | BRAIN SPECIFIC DELIVERY | authKW | 187616 | 1% | 67% | 4 |
| 6 | MOL CELLULAR PHARMACOL DIABET | address | 158302 | 1% | 75% | 3 |
| 7 | SOFT CORTICOSTEROID | authKW | 158302 | 1% | 75% | 3 |
| 8 | ESTER STEROID | authKW | 140714 | 0% | 100% | 2 |
| 9 | KETONE STEROID | authKW | 140714 | 0% | 100% | 2 |
| 10 | REDOX DELIVERY SYSTEM | authKW | 140714 | 0% | 100% | 2 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Chemistry, Medicinal | 3471 | 27% | 0% | 116 |
| 2 | Pharmacology & Pharmacy | 2540 | 45% | 0% | 195 |
| 3 | Ophthalmology | 1524 | 16% | 0% | 71 |
| 4 | Chemistry, Multidisciplinary | 553 | 25% | 0% | 108 |
| 5 | Chemistry, Organic | 133 | 9% | 0% | 41 |
| 6 | Endocrinology & Metabolism | 16 | 4% | 0% | 16 |
| 7 | Medicine, Research & Experimental | 12 | 3% | 0% | 14 |
| 8 | Allergy | 5 | 1% | 0% | 3 |
| 9 | Medicine, General & Internal | 3 | 3% | 0% | 13 |
| 10 | Primary Health Care | 1 | 0% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MOL CELLULAR PHARMACOL DIABET | 158302 | 1% | 75% | 3 |
| 2 | ANAL PHARM CHEM | 70357 | 0% | 100% | 1 |
| 3 | BIO DEV MARSEILLE CHIM BIOMOL | 70357 | 0% | 100% | 1 |
| 4 | CEA DSV I2BM CI N S | 70357 | 0% | 100% | 1 |
| 5 | CHEM PHARM DRUG EVALUAT | 70357 | 0% | 100% | 1 |
| 6 | CHIM BIOMOL SCI LUMINY | 70357 | 0% | 100% | 1 |
| 7 | CT DRUG DISCOVERY | 70357 | 0% | 100% | 1 |
| 8 | DR BR AMBEDKAR BIOMED SCI | 70357 | 0% | 100% | 1 |
| 9 | DSVI2BMCI N SUMR6232 | 70357 | 0% | 100% | 1 |
| 10 | INSERM U623 | 70357 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ALLERGY & CLINICAL IMMUNOLOGY INTERNATIONAL-JOURNAL OF THE WORLD ALLERGY ORGANIZATION | 7212 | 0% | 5% | 2 |
| 2 | PHARMAZIE | 6633 | 7% | 0% | 29 |
| 3 | PHARMACEUTICAL RESEARCH | 5047 | 6% | 0% | 24 |
| 4 | SOAP & COSMETICS | 4689 | 0% | 7% | 1 |
| 5 | ADVANCED DRUG DELIVERY REVIEWS | 2618 | 2% | 0% | 10 |
| 6 | JOURNAL OF MEDICINAL CHEMISTRY | 2542 | 6% | 0% | 28 |
| 7 | JOURNAL OF PHARMACEUTICAL SCIENCES | 2244 | 4% | 0% | 19 |
| 8 | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | 1544 | 1% | 0% | 6 |
| 9 | ARCHIV DER PHARMAZIE | 1034 | 2% | 0% | 8 |
| 10 | BRITISH JOURNAL OF OPHTHALMOLOGY | 897 | 3% | 0% | 11 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LOTEPREDNOL ETABONATE | 1064137 | 5% | 69% | 22 | Search LOTEPREDNOL+ETABONATE | Search LOTEPREDNOL+ETABONATE |
| 2 | CHEMICAL DELIVERY SYSTEM | 651288 | 4% | 51% | 18 | Search CHEMICAL+DELIVERY+SYSTEM | Search CHEMICAL+DELIVERY+SYSTEM |
| 3 | NBP ASSAY | 351785 | 1% | 100% | 5 | Search NBP+ASSAY | Search NBP+ASSAY |
| 4 | SOFT DRUGS | 271367 | 2% | 43% | 9 | Search SOFT+DRUGS | Search SOFT+DRUGS |
| 5 | BRAIN SPECIFIC DELIVERY | 187616 | 1% | 67% | 4 | Search BRAIN+SPECIFIC+DELIVERY | Search BRAIN+SPECIFIC+DELIVERY |
| 6 | SOFT CORTICOSTEROID | 158302 | 1% | 75% | 3 | Search SOFT+CORTICOSTEROID | Search SOFT+CORTICOSTEROID |
| 7 | ESTER STEROID | 140714 | 0% | 100% | 2 | Search ESTER+STEROID | Search ESTER+STEROID |
| 8 | KETONE STEROID | 140714 | 0% | 100% | 2 | Search KETONE+STEROID | Search KETONE+STEROID |
| 9 | REDOX DELIVERY SYSTEM | 140714 | 0% | 100% | 2 | Search REDOX+DELIVERY+SYSTEM | Search REDOX+DELIVERY+SYSTEM |
| 10 | SOFT BETA BLOCKERS | 140714 | 0% | 100% | 2 | Search SOFT+BETA+BLOCKERS | Search SOFT+BETA+BLOCKERS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BODOR, N , (1999) RECENT ADVANCES IN RETROMETABOLIC DESIGN APPROACHES.JOURNAL OF CONTROLLED RELEASE. VOL. 62. ISSUE 1-2. P. 209 -222 | 63 | 85% | 13 |
| 2 | BODOR, N , BUCHWALD, P , (1999) RECENT ADVANCES IN THE BRAIN TARGETING OF NEUROPHARMACEUTICALS BY CHEMICAL DELIVERY SYSTEMS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 36. ISSUE 2-3. P. 229 -254 | 56 | 56% | 84 |
| 3 | PROKAI, L , PROKAI-TATRAI, L , BODOR, N , (2000) TARGETING DRUGS TO THE BRAIN BY REDOX CHEMICAL DELIVERY SYSTEMS.MEDICINAL RESEARCH REVIEWS. VOL. 20. ISSUE 5. P. 367 -416 | 65 | 45% | 69 |
| 4 | BODOR, N , (2000) RECENT ADVANCES IN RETROMETABOLIC DRUG DESIGN AND TARGETING APPROACHES.PHARMAZIE. VOL. 55. ISSUE 3. P. 163-166 | 33 | 94% | 12 |
| 5 | BODOR, N , BUCHWALD, P , (1999) RETROMETABOLIC DRUG DESIGN: PRINCIPLES, EXAMPLES AND COMPUTATIONAL TECHNIQUES.MAGYAR KEMIAI FOLYOIRAT. VOL. 105. ISSUE 9. P. 337 -362 | 56 | 51% | 1 |
| 6 | BODOR, N , BUCHWALD, P , (2000) SOFT DRUG DESIGN: GENERAL PRINCIPLES AND RECENT APPLICATIONS.MEDICINAL RESEARCH REVIEWS. VOL. 20. ISSUE 1. P. 58 -101 | 57 | 41% | 104 |
| 7 | SHEPPARD, JD , COMSTOCK, TL , CAVET, ME , (2016) IMPACT OF THE TOPICAL OPHTHALMIC CORTICOSTEROID LOTEPREDNOL ETABONATE ON INTRAOCULAR PRESSURE.ADVANCES IN THERAPY. VOL. 33. ISSUE 4. P. 532 -552 | 28 | 58% | 1 |
| 8 | JAIN, V , KISHORE, D , BHARDWAJ, YR , PAREEK, A , (2014) CHEMICAL DELIVERY SYSTEMS AND SOFT DRUGS: RETROMETABOLIC APPROACHES OF DRUG DESIGN.SAUDI PHARMACEUTICAL JOURNAL. VOL. 22. ISSUE 4. P. 290 -302 | 24 | 73% | 0 |
| 9 | COMSTOCK, TL , PATERNO, MR , BATEMAN, KM , DECORY, HH , GEARINGER, M , (2012) SAFETY AND TOLERABILITY OF LOTEPREDNOL ETABONATE 0.5% AND TOBRAMYCIN 0.3% OPHTHALMIC SUSPENSION IN PEDIATRIC SUBJECTS.PEDIATRIC DRUGS. VOL. 14. ISSUE 2. P. 119-130 | 22 | 81% | 2 |
| 10 | BUCHWALD, P , BODOR, N , (2016) BRAIN-TARGETING CHEMICAL DELIVERY SYSTEMS AND THEIR CYCLODEXTRIN-BASED FORMULATIONS IN LIGHT OF THE CONTRIBUTIONS OF MARCUS E. BREWSTER.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 105. ISSUE 9. P. 2589 -2600 | 36 | 42% | 1 |
Classes with closest relation at Level 1 |